A Delhi court has issued a permanent injunction against Hyderabad-based Sainus Pharmaceutical Private Limited, prohibiting it from using the 'Udaan' trademark. The ruling favors RSPL Health, the maker of 'Ghari' detergent, which holds the 'Udan' mark for sanitary napkins. The court also ordered the confiscation of all infringing products and materials, highlighting the operational risks of trademark disputes.
A Delhi court has permanently restrained Hyderabad-based Sainus Pharmaceutical Private Limited from using the trademark 'Udaan' or any visually similar variations. The ruling, delivered by District Judge Pankaj Sharma on August 13, 2026, stems from a legal battle over trademark infringement and passing off.
The Legal Dispute
The case was brought forward by RSPL Health Private Limited, a company widely known for its 'Ghari' detergent brand. RSPL Health argued that it had adopted the 'Udan' trademark for its sanitary napkin products as early as 2007. The company contended that Sainus Pharmaceutical’s use of the name 'Udaan' was identical and deceptively similar to its own registered mark, creating confusion among consumers. The court found that the defendant, Sainus Pharmaceutical, failed to appear for the proceedings, leading to an ex parte judgment that sided with RSPL Health.
Impact on Business Operations
For businesses, this court order serves as a clear example of the significant operational and financial risks associated with intellectual property disputes. When a company is found to be using an infringing trademark, the consequences extend beyond legal fees and litigation time. In this case, the court has mandated the confiscation and delivery of all seized counterfeit products, including packaging, dies, and printing blocks, to RSPL Health for destruction.
Such a ruling forces a company to immediately stop using the brand name, which can lead to a sudden loss of inventory, wasted marketing expenditure, and the necessity to rebrand products. These actions can cause significant disruption to a company's sales channel and weaken its market position. The court noted that RSPL Health had provided evidence that the infringing products were being sold in various New Delhi markets, including areas like Parliament Street and Connaught Place, posing a risk to the brand value of the original owner.
Why Investors Monitor IP Rights
Intellectual property, such as trademarks and brand names, is a key intangible asset for companies, particularly in the fast-moving consumer goods and pharmaceutical sectors. Investors often view the strength of a brand as a protective advantage. Conversely, when a company is involved in litigation over its own brand name or is accused of infringing on another's, it introduces uncertainty.
Successful trademark challenges by competitors or established brands can force companies to retreat from markets, incur one-time write-offs, and face reputational damage. As this case moves forward, the primary monitorables for stakeholders involved in such disputes are the costs of compliance, the ability to continue business operations under a new brand identity if required, and the finality of the court's enforcement actions regarding the destruction of goods.